I am planning to use AAV vector to express a gene product in the brain in a standard protocol. I am in the process of getting biosafety approval.
I understand that AAV vector mediated expression lasts a long time, but how long does the vector itself continue to be active/infectious after injection?
The question is related to safety approval, essentially:
How long after AAV vector injection can the tissue be treated like wild type tissue with no infection risk?
I found this article: Comp Med. Oct 2012; 62(5): 361–37 which suggest a about a week but have not found it easy to find corroborating evidence.
Thanks for your help